4//SEC Filing
Holdbrook Mark J. 4
Accession 0001209191-21-018041
CIK 0001819790other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:14 PM ET
Size
5.5 KB
Accession
0001209191-21-018041
Insider Transaction Report
Form 4
Holdbrook Mark J.
V.P., Clinical Affairs
Transactions
- Award
Stock Option (right to buy)
2021-03-02+14,300→ 14,300 totalExercise: $34.72Exp: 2031-03-02→ Common Stock (14,300 underlying)
Footnotes (1)
- [F1]Option granted under the Tarsus Pharmaceuticals, Inc. 2020 Equity Incentive Plan. 25% of the option shares shall vest and become exercisable on March 2, 2022, and 1/48th of the option shares shall vest and become exercisable each month thereafter for a period of 3 years.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827564
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:14 PM ET
- Size
- 5.5 KB